Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands
Authors
Keywords
Cost-effectiveness analysis, HIV epidemiology, Hepatitis C virus, Fibrosis, Drug therapy, HIV, Infectious disease epidemiology, Netherlands
Journal
PLoS One
Volume 11, Issue 10, Pages e0163488
Publisher
Public Library of Science (PLoS)
Online
2016-10-07
DOI
10.1371/journal.pone.0163488
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-effectiveness of Interferon-free therapy for Hepatitis C in Germany - an application of the efficiency frontier approach
- (2015) Christian Gissel et al. BMC INFECTIOUS DISEASES
- High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance
- (2015) Magdalena Rosińska et al. BMC INFECTIOUS DISEASES
- EASL Recommendations on Treatment of Hepatitis C 2015
- (2015) JOURNAL OF HEPATOLOGY
- Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study
- (2015) Jean-Michel Molina et al. LANCET
- Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1
- (2015) David L. Wyles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment as prevention among injecting drug users; extrapolating from the Amsterdam cohort study
- (2014) Anneke S. de Vos et al. AIDS
- Temporal trends in mortality among people who use drugs compared with the general Dutch population differ by hepatitis C virus and HIV infection status
- (2014) Daniëla K. van Santen et al. AIDS
- Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C
- (2014) Salvatore Petta et al. HEPATOLOGY
- Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens
- (2014) Zobair M. Younossi et al. HEPATOLOGY
- Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individuals
- (2014) Liesl M. Hagan et al. HEPATOLOGY
- HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact
- (2014) N. K. Martin et al. JOURNAL OF VIRAL HEPATITIS
- Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis C
- (2014) H. Leleu et al. JOURNAL OF VIRAL HEPATITIS
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
- (2014) Mark S. Sulkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention
- (2014) Lucas Wiessing et al. PLoS One
- Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?
- (2013) Anneke S. de Vos et al. ADDICTION
- Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study
- (2013) Shannon Allen Ferrante et al. BMC INFECTIOUS DISEASES
- Assessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS Study
- (2013) Maryam Alavi et al. CLINICAL INFECTIOUS DISEASES
- Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics
- (2013) Anuoluwapo Osinusi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus-Coinfected Patients With Compensated Liver Cirrhosis
- (2012) J. A. Mira et al. CLINICAL INFECTIOUS DISEASES
- The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam
- (2011) Amy Matser et al. ADDICTION
- Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations
- (2011) Natasha K. Martin et al. HEPATOLOGY
- Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews
- (2011) Paul K Nelson et al. LANCET
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatitis C testing and treatment among active drug users in Amsterdam
- (2010) Catharina E.A. Lindenburg et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men
- (2010) E. C. Thomson et al. GUT
- Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis
- (2008) Hla-Hla Thein et al. AIDS
- Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
- (2008) Hla-Hla Thein et al. HEPATOLOGY
- Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in HIV‐Infected Patients with Anti‐HCV Antibodies in Europe
- (2008) Vincent Soriano et al. JOURNAL OF INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now